Phase 1 first-in-human dose-escalation study of IMSA101, a novel cyclic di-nucleotide STING agonist, for patients with advanced solid tumor malignancies.
Journal for immunotherapy of cancer · 2025 · 20 citations · Syed Kazmi
Assessment of Functional Pain Score by Comparing to Traditional Pain Scores.
Cureus · 2021 · 39 citations · Sri Senapathi
The phosphatidylserine targeting antibody bavituximab plus pembrolizumab in unresectable hepatocellular carcinoma: a phase 2 trial.
Nature communications · 2024 · 36 citations · Syed Kazmi
A Propensity Score Analysis of Chemotherapy Use in Patients With Resectable Gallbladder Cancer.
JAMA network open · 2022 · 35 citations · Syed Kazmi
Early Palliative Care Is Associated With Reduced Emergency Department Utilization in Pancreatic Cancer.
American journal of clinical oncology · 2021 · 42 citations · Syed Kazmi
NCI9673 (Part B): ETCTN Randomized Phase II Study of Nivolumab With or Without Ipilimumab in Refractory, Metastatic Squamous Cell Carcinoma of the Anal Canal.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2026 · 5 citations · Syed Kazmi
Effects of Dietary App-Supported Tele-Counseling on Sodium Intake, Diet Quality, and Blood Pressure in Patients With Diabetes and Kidney Disease.
Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation · 2022 · 22 citations · Apurva Inamdar
VEGFR2 activity on myeloid cells mediates immune suppression in the tumor microenvironment.
JCI insight · 2021 · 56 citations · Syed Kazmi